Modulation of the pacemaker current i(f) by β-adrenoceptor subtypes in ventricular myocytes isolated from hypertensive and normotensive rats

Cardiovascular Research

Volumn 42, Issue 1, 1999, Pages 121-129

  Cerbai, Elisabetta ^a   Pino, Roberto ^a   Rodriguez, Maria L ^b   Mugelli, Alessandro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Instituto Nacional de Toxicologia   (Spain)

Author keywords

adrenergic receptors; G proteins; Hypertrophy; Membrane currents; Myocytes

Indexed keywords

5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ADENOSINE DERIVATIVE; BETA 1 ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; NORADRENALIN; PERTUSSIS TOXIN; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC STIMULATION; HEART ARRHYTHMIA; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE POTENTIAL; HEART RHYTHM; HEART VENTRICLE PACING; HYPERTENSION; MALE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SPONTANEOUSLY HYPERTENSIVE RAT;

ACTION POTENTIALS; ADENOSINE; ADRENERGIC BETA-AGONISTS; ANIMALS; CARDIOMEGALY; CATECHOLAMINES; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HYPERTENSION; IMIDAZOLES; ISOPROTERENOL; MALE; MYOCARDIUM; NOREPINEPHRINE; PATCH-CLAMP TECHNIQUES; PERTUSSIS TOXIN; PROPANOLAMINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; STIMULATION, CHEMICAL; VIRULENCE FACTORS, BORDETELLA;

EID: 0032895801     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00291-0     Document Type: Article

References (43)

1. Levy D., Larson M.G., Basal R.S., Kannel W.B., Ho K.L. The progression from hypertension to congestive heart failure. J Am Med Assoc. 275:1996;1557-1562.
2. Bohm M., Lohse M.J. Quantification of beta-adrenoceptors and beta-adrenoceptor kinase on protein and mRNA levels in heart failure. Eur Heart J. 15(Suppl D):1994;30-34.
3. Bohm M. Alterations of beta-adrenoceptor-G-protein-regulated adenylyl cyclase in heart failure. Mol Cell Biochem. 147:1995;147-160.
4. 2-adrenoceptor function by beta-adrenoceptor agonists and antagonists. Clin Physiol Biochem. 8(Suppl 2):1990;11-17.
5. Harding S.E., Davies C.H., Wynne D.G., Poole-Wilson P.A. Contractile function and response to agonists in myocytes from failing human heart. Eur Heart J. 15(Suppl D):1994;35-36.
6. Feldman A.M., Jackson D.G., Bristow M.R., Cates A.E., Van D.C. Immunodetectable levels of the inhibitory guanine nucleotide-binding regulatory proteins in failing human heart: discordance with measurements of adenylate cyclase activity and levels of pertussis toxin substrate. J Mol Cell Cardiol. 23:1991;439-452.
7. Feldman A.M., Ray P.E., Bristow M.R. Expression of alpha-subunits of G proteins in failing human heart: a reappraisal utilizing quantitative polymerase chain reaction. J Mol Cell Cardiol. 23:1991;1355-1358.
8. Neumann J., Schmitz W., Scholz H.et al. Increase in myocardial Gi-proteins in heart failure. Lancet. 2:1988;936-937.
9. 1-receptor down-regulation in heart failure. Circ Res. 59:1986;297-309.
10. Ungerer M., Bohm M., Elce J.S., Erdmann E., Lohse M.J. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation. 87:1993;454-463.
11. Bristow M.R., Minobe W.A., Raynolds M.V.et al. Reduced beta-1 receptor messenger RNA abundance in the failing human heart. J Clin Invest. 92:1993;2737-2745.
12. Castellano M., Bohm M. The cardiac beta-adrenoceptor-mediated signaling pathway and its alterations in hypertensive heart disease. Hypertension. 29:1997;715-722.
13. Atkins F.L., Bing O.H., DiMauro P.G.et al. Modulation of left and right ventricular beta-adrenergic receptors from spontaneously hypertensive rats with left ventricular hypertrophy and failure. Hypertension. 26:1995;78-82.
14. Bing O.H., Brooks W.W., Robinson K.G.et al. The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. J Mol Cell Cardiol. 27:1995;383-396.
15. Cerbai E., Barbieri M., Li Q., Mugelli A. Ionic basis of action potential prolongation of hypertrophied cardiac myocytes isolated from hypertensive rats of different ages. Cardiovasc Res. 28:1994;1180-1187.
16. + currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res. 73:1993;379-385.
17. Tomaselli G.F., Beuckelmann D.J., Calkins H.G.et al. Sudden cardiac death in heart failure. The role of abnormal repolarization. Circulation. 90:1994;2534-2539.
18. f in ventricular myocytes from normotensive and hypertensive rats during aging. Circulation. 94:1996;1674-1681.
19. Cerbai E., Barbieri M., Porciatti F., Mugelli A. Ionic channels in hypertrophy and heart failure: relevance for arrhythmogenesis. New Trends Arrhythmias. 11:1995;135-139.
20. f, in ventricular myocytes from human failing heart. Circulation. 95:1997;568-571.
21. Hoppe U.C., Jansen E., Sudkamp M., Beuckelmann D.J. Hyperpolarization-activated inward current in ventricular myocytes from normal and failing human hearts. Circulation. 97:1998;55-65.
22. Barbieri M., Varani K., Cerbai E.et al. Electrophysiological basis for the enhanced cardiac arrhythmogenic effect of isoprenaline in aged spontaneously hypertensive rats. J Mol Cell Cardiol. 26:1994;849-860.
23. 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol. 47:1995;322-329.
24. 2-adrenergic modulation of cardiac excitation-contraction coupling. Am J Physiol. 273:1997;H1611-H1618.
25. 2+ dynamics, contractility, or phospholamban phosphorylation. J Biol Chem. 269:1994;19151-19156.
26. 2-adrenoceptors in sheep Purkinje fibers. J Mol Cell Cardiol. 22:1990;859-870.
27. 2+ current in single rat ventricular cells. Circ Res. 73:1993;286-300.
28. f, in ventricular myocytes isolated from hypertensive rats. J Physiol (Lond). 481:1994;585-591.
29. 1-selective adenosine agonists. J Med Chem. 28:1985;1383-1384.
30. 2-adrenoceptors. Eur J Pharmacol. 130:1986;137-139.
31. 2-selective adrenoceptor antagonist (ICI 118,551). J Cardiovasc Pharmacol. 5:1983;430-437.
32. DiFrancesco D. Pacemaker mechanisms in cardiac tissue. Annu Rev Physiol. 55:1993;455-472.
33. 2-adrenoceptors in sheep cardiac ventricular muscle. J Mol Cell Cardiol. 24:1992;753-763.
34. f) by cAMP gating and phosphatase inhibition in rabbit sino-atrial node myocytes. J Physiol (Lond). 500:1997;643-651.
35. DiFrancesco D., Tortora P. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature. 351:1991;145-147.
36. Bois P., Renaudon B., Baruscotti M., Lenfant J., DiFrancesco D. Activation of f-channels by cAMP analogues in macropatches from rabbit sino-atrial node myocytes. J Physiol (Lond). 501:1997;565-571.
37. 2-adrenergic responses without changes in inhibitory G proteins or receptor kinases. J Clin Invest. 101:1998;1273-1282.
38. Bohm M., Castellano M., Paul M., Erdmann E. Cardiac norepinephrine, beta-adrenoceptors, and Gi alpha-proteins in prehypertensive and hypertensive spontaneously hypertensive rats. J Cardiovasc Pharmacol. 23:1994;980-987.
39. White M., Roden R., Minobe W.et al. Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation. 90:1994;1225-1238.
40. Cerbai E., Guerra L., Varani K.et al. Beta-adrenoceptor subtypes in young and old rat ventricular myocytes: a combined patch-clamp and binding study. Br J Pharmacol. 116:1995;1835-1842.
41. Muller F.U., Boheler K.R., Eschenhagen T., Schmitz W., Scholtz H. Isoprenaline stimulates gene transcription of the inhibitory G-protein alpha-subunit Gi-alpha-2 in rat heart. Circ Res. 72:1993;696-700.
42. Cerbai E., Pino R., Sartiani L.et al. Arrhythmogenic alterations in failing human ventricular myocytes. G Ital Cardiol. 28:1998;155-159.
43. 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. Mol Pharmacol. 35:1989;295-303.